Selective Inhibition of Bruton’s Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors
Bárbara B. Sousa(University of Lisbon), Gonçalo J. L. Bernardes(University of Lisbon)
Cited by 9
Related Papers
Inverse electron demand Diels–Alder reactions in chemical biology
|Chemical Society Reviews|2017|1.1k
A Selective SARS-CoV-2 Host-Directed Antiviral Targeting Stress Response to Reactive Oxygen Species
|ACS Central Science|2023|8
Tumour-specific STING agonist synthesis via a two-component prodrug system
|Nature Chemistry|2025|4